Oral 24-week probiotics supplementation did not decrease cardiovascular risk markers in patients with biopsy proven NASH: A double-blind placebo-controlled randomized study Samantha Thifani Alrutz Barcelos; Amanda Souza Silva-Sperb; Helena Abadie Moraes; Larisse Longo; Bruna Concheski de Moura; Matheus Truccolo Michalczuk; Carolina Uribe-Cruz; Carlos Thadeu Schmidt Cerski; Themis Reverbel da Silveira; Valesca Dall'Alba; Mário Reis Álvares-da-Silva;

New FIB-4 and NFS cutoffs to guide sequential non-invasive assessment of liver fibrosis by magnetic resonance elastography in NAFLD Louise Torres; Alice Schuch; Larisse Longo; Bruna Bressan Valentini; Gabriela Schneider Galvão; Eduardo Luchese; Carlos Pinzon; Rodrigo Bartels; Mário Reis Álvares-da-Silva;

Usefulness of collagen type IV in the detection of significant liver fibrosis in nonalcoholic fatty liver disease José Tadeu Stefano; Laura Vilar Guedes; Arthur Alencar Arrais de Souza; Denise Siqueira Vanni; Venâncio Avancini Ferreira Alves; Flair José Carrilho; Alvaro Largura; Marco Arrese; Claudia P. Oliveira;